RP treatment improved motor strength and reduced the expression of the ALS progression marker collagen type XIXα1 (Col19α1 mRNA) in the quadriceps muscle in SOD1G93A mice. This evidence concerns the gene COL19A1 and amyotrophic lateral sclerosis.